CD163 and myocarditis: The dominant role of reparative macrophages in the later phase of DOX-induced myocardial inflammation supports our finding that, after eight weeks of DOX treatment, the expression of the anti-inflammatory macrophage marker CD163 but not CD86 was significantly increased compared to CTRL.